Clinical Trial Update: MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

View source ↗

Summary

MECKI-Amyloidosis is a study assessing exercise capacity and prognosis in cardiac amyloidosis patients. The trial is currently recruiting, sponsored by Centro C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Snippet

Sponsor: Centro Cardiologico Monzino | Conditions: Cardiac Amyloidosis | Status: RECRUITING